New treatment option for Stroke
Official title Better Understanding of Fatigue After STroke
ClinicalTrials.gov ID: NCT06292377
What this study is testing
- What it's testing
- Stroke is worldwide the second most common cause of death following heart attack and the leading cause of disability. Post-stroke fatigue (PSF) is a common complication after stroke and can be defined as 'an overwhelming exhaustion or tiredness, not related to exertion, which does not typically improve with rest'.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18
- First-ever (suspicion of) ischemic stroke based on clinical examination and/or brain imaging
- Onset \< 72h at time of inclusion
- Admitted at the stroke unit of CHU Brugmann and UZ Brussel
- Ability to participate in assessment of fatigue, cognitive, mood and sleep disturbances
You likely can't join if
- Unable to speak French or Dutch
- Pre-existing stroke or other structural brain lesion
- Life expectancy \< 1 year
- Severe language impairment or dementia impeding assessment of fatigue, cognitive, mood and sleep disturbances
- Pregnancy or wish to become pregnant
See the full eligibility criteria
- Age ≥ 18
- First-ever (suspicion of) ischemic stroke based on clinical examination and/or brain imaging
- Onset \< 72h at time of inclusion
- Admitted at the stroke unit of CHU Brugmann and UZ Brussel
- Ability to participate in assessment of fatigue, cognitive, mood and sleep disturbances
- Ability to undergo MRI of the brain
- Unable to speak French or Dutch
- Pre-existing stroke or other structural brain lesion
- Life expectancy \< 1 year
- Severe language impairment or dementia impeding assessment of fatigue, cognitive, mood and sleep disturbances
- Pregnancy or wish to become pregnant
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.